Key terms
About MEIP
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MEIP news
Feb 21
4:14pm ET
MEI Pharma Announces Flexible $25 Million Funding Strategy
Feb 20
5:35pm ET
MEI Pharma files $100M mixed securities shelf
Feb 14
7:41am ET
MEI Pharma price target lowered to $7 from $8 at Stifel
Dec 11
12:06pm ET
MEI Pharma reports clinical data on oral CDK9 inhibitor voruciclib at ASH 2023
No recent news articles are available for MEIP
No recent press releases are available for MEIP
MEIP Financials
Key terms
Ad Feedback
MEIP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MEIP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range